Lost in translation? Report as inadecuate




Lost in translation? - Download this document for free, or read online. Document in PDF available to download.

Trends in Psychiatry and Psychotherapy 2013, 35 4

Author: Olavo B. Amaral

Source: http://www.redalyc.org/articulo.oa?id=311029500001


Teaser



Trends in Psychiatry and Psychotherapy ISSN: 2237-6089 trends.denise@gmail.com Associação de Psiquiatria do Rio Grande do Sul Brasil Amaral, Olavo B. Lost in translation? Trends in Psychiatry and Psychotherapy, vol.
35, núm.
4, 2013, pp.
235-237 Associação de Psiquiatria do Rio Grande do Sul Available in: http:--www.redalyc.org-articulo.oa?id=311029500001 How to cite Complete issue More information about this article Journals homepage in redalyc.org Scientific Information System Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Non-profit academic project, developed under the open access initiative Trends Editorial in Psychiatry and Psychotherapy Lost in translation? Perdidos na tradução? Olavo B.
Amaral* No one with a background in literary theory would dare to say that translation is a trivial matter.
It is a science as much as an art, and seminal translations have been as important as original literary material in many cultural scenes.
It is also hard work: a recent translation of the first third of Joyce’s Finnegans Wake has recently come out in China after 8 years of labor by its author.1 Still, hardly anyone would consider the difficulty of translation as a reason to abolish linguistic diversity and establish a universal language.
Although we evidently need communication between different societies, much of our cultural richness comes precisely from diversity, and many people dedicate their lives to making sure that the uniqueness of a particular language is preserved from globalization.2 These facts may seem distant from psychiatric research, but the connection is not that far-fetched.
The concept of translational science has invaded the biomedical field over the last two decades, starting out in cancer research in the early 1990s3 and rapidly progressing to guide a number of initiatives around the world, including the 2003 NIH Road Map,4 the 2004 FDA Critical Path Initiative,5 and the 2005 NIH Clinical a...





Related documents